USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 76 – 100 of 6410 Awards
Company: CELL AND TISSUE SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …ed articular cartilage is accepted as one of the determinants of outcome following osteochondral allograft transplantation. Refrigerated storage methods used for cartilage storage prior to clinical cartilage utilization need to be carefully evaluated because the tissue may be… more
Company: CELL AND TISSUE SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … will include 1) cell viability and proliferation, 2) base line adipogenic differentiation, and 3) response to obesogen(s). Feasibility for progression to Phase II will be demonstration of gt70% viability, cell survival with retention of attachment to the tissue culture… more
Company: CFD Research Corporation Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: …, security, and defense, among others. To study safety and potential health hazards of EM devices, high-fidelity voxelized anatomical body models have been used in conjunction with sophisticated EM and thermal solvers to predict energy absorption rates and tissue… more
Company: CHARLESSON, LLP Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … disease. The Wnt pathway mediates multiple pathological processes, including angiogenesis, vascular permeability, inflammation and fibrosis, as it regulates many pathogenic factors, such as VEGF, tumor necrosis factor-alpha(TNF- ), intercellular adhesion… more
Company: Coating Technology Solutions Inc. Agency/Program/Year/Phase: DOE / SBIR / 2013 / 2
Abstract: …reproducibility and homogeneity. Commercial Applications and Other Benefits: Diamonds radiation hardness and many other unique properties are propelling it to important roles in DOE & apos;s discovery efforts in fundamental physics. Diamond is promising as a tissue… more
Company: COHERA MEDICAL, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Seroma formation (fluid accumulation in the wound) is among the most common post-surgical complications, occurring in up to 50% of certain surgical procedures. TissuGlu(R) Surgical Adhesive is designed to adhere flaps of… more
Company: Giner Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … for 50% of the recipients. However, widespread clinical application of for T1D is hindered by two critical barriers: 1) the need for systemic immunosuppression for the current intraportal liver transplant site; and 2) by the finite and low supply of human islet tissue (a… more
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: …, at 1 week, 2 weeks, 6 weeks, and 12 weeks in the live animals, and at the 12 and 24-week sacrifice dates. Following necropsy joints will be evaluated byCT and gross and histological semi- quantitative scoring. In addition, mechanical properties of repair tissue, the… more
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): The overall goal of this study is to develop a tissue-engineered total joint replacement from an engineered biomaterial scaffold combined with adult bone marrow-derived mesenchymal stem cells (MSCs) for regeneration ofthe entire femoral… more
Company: CYTOGRAFT TISSUE ENGINEERING, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … would benefit from a less invasive procedure. Expanded use of TAVI devices will also have a positive economic impact on the healthcare system, with decreased O.R. times, shorter hospital stays, and reduced complication rates. We have developed a technology called '… more
Company: DEKK-TEC, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: …, monitor pharmacodynamics and toxicities. 2) Monitor tumor responses to DM-CHOC-PEN per imaging/examinations using RECIST guidelines. 3) Electronically store/analyze clinical data for toxicity, responses and tumor-organrelationships. 4) Continue to bank tumor tissue from pre-… more
Company: Deployable Space Systems (DSS) Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: ABSTRACT: Deployable Space Systems, Inc. (DSS), in partnership with Emcore Photovoltaics (EMCORE), proposes the development and TRL 5/6 validation of an adhesive-less photovoltaic panel assembly, termed"HSA"for High Survivability Array. Space solar array adhesives… more
Company: DMETRIX, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The ability to accurately detect the developing lesions at early stage in dental practice and to quantify the lesions will provide dentists with the opportunity of initiating early prophylactic treatment; correct diagnosis of a fractured tooth in is earliest… more
Company: DYNAVAX TECHNOLOGIES CORPORATION Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: …, blocks the development of HF when given prophylactically. This project attempts to confirm and expand the preclinical feasibility data and potential for IRS954 to be a novel therapy for HF with the following Specific Aims: Aim 1: Evaluate the pharmacokinetics and tissue… more
Company: Ecovative Design LLC Agency/Program/Year/Phase: EPA / SBIR / 2013 / 1
Abstract: …, but all attempts have still fallen short of an ideal ‘bio-plastic’. §The proposed concept is to demonstrate an ideal bio-plastic by using mycelium as the polymer, resin, or structural matrix. Preliminary studies have shown basidiomycete stipe tissue offers… more
Company: ENSION, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … proposes development of an infection resistant surface designed to promote normal healing for application to the transcutaneous drivelines of ventricular assist devices. Theproposed surface will incorporate a three-pronged approach to infection resistance; a low adhesion… more
Company: PROSOLIA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … that enable rapid measurements without significant compromise to the analytical data. Herein, we propose to develop arobust mass spectrometry (MS) based surface sampling device that enables direct analysis of a variety of materials including biological tissue and live… more
Company: Excellims Corporation Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION: The ultimate goal of the Phase I SBIR project is to establish the feasibility of using ion mobility spectrometry (IMS) or liquid chromatography-IMS (LC-IMS) as a fast, selective and sensitive method for rapid monitoring of bio manufacturing processes for on-line use to improve the… more
Company: Luna Innovations Incorporated Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Adhesion formation after intra-abdominal surgery poses a significant health risk, cited as a leading cause of small bowel obstruction and female infertility. Methods to prevent these adhesions are currently limited to barrier films which are… more
Company: FBS, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: …cing conditions are encountered to perform de-icing of the wing leading edge. Ultrasonic de-icing is achieved by driving the actuators to create ultrasonic shear stresses at the substrate/ice interface such that the ultrasonic stresses are greater than the adhesion strength of… more
Company: FOCALCOOL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … also enables destructive biochemical processes. While numerousadjunctive therapies for acute myocardial infarctions (AMI) have been studied, innovative combination therapies are needed. Both hypothermia and gradual reperfusion have shown benefit in terms of saving heart tissue… more
Company: NANO TERRA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: Not Available
Company: GENOMICS USA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … prototype (microarrays, PCR reagents, Hybridization Reagents, Specialized Software) for subsequent Beta Testing. This kit will be prepared under manufacturing control (ISO 13845) similar to the HLA-Chip products from GenUSA which are currently being launched into tissue… more
Company: GLSYNTHESIS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …mster flank, reduced the size of this organ but only on the ipsilateral side These results suggest that this drug is a soft antiandrogen , expected to be active topically inandrogen-dependent maladies of the skin and scalp, but to be hydrolyzed by plasma or tissue enzymes, thus… more
Company: ADVAITA CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … medicine and drug discovery. To realize the much-heralded promise of personalized medicine, it is necessary to (a) accurately recognize and distinguish disease subtypes, (b) apply these diagnostic signatures at the level of the individual patient (and tissue type) over… more
Displaying 76 – 100 of 6410 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.